Galmed Pharmaceuticals Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$6,912,000 over the previous period. Total operating expenses were -$7,492,000.
Profit Margin
| 2014 | 0 | -9.10M | |
|---|---|---|---|
| 2015 | 0 | -10.62M | |
| 2016 | 467K | -16.95M | -3630.19% |
| 2017 | 1.08M | -12.29M | -1133.55% |
| 2018 | 2.03M | -9.85M | -483.61% |
| 2019 | 0 | -18.54M | |
| 2020 | 0 | -27.61M | |
| 2021 | 0 | -31.94M | |
| 2022 | 0 | -18.57M | |
| 2023 | 0 | -6.91M |
GLMD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 2.03M | 1.08M | 467K | 0 | 0 |
Cost of revenue | 31K | 35K | 42K | 39K | 35K | 0 | 0 | 0 | 50K | 0 |
Gross profit | -31K | -35K | -42K | -39K | -35K | 2.03M | 1.08M | 467K | -50K | 0 |
Operating exp. | ||||||||||
Research and development | 3.56M | 12.99M | 27.22M | 26.08M | 18.18M | 8.31M | 9.65M | 14.27M | 7.62M | 6.66M |
Selling and marketing | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | -7.49M | 17.65M | 32.88M | 30.21M | 22.37M | 12.75M | 13.44M | 17.34M | 10.87M | 9.14M |
Operating income | 7.49M | -17.65M | -32.88M | -30.21M | -22.37M | -10.71M | -12.36M | -16.88M | -10.87M | -9.14M |
Other income (expenses), net | -14.40M | -215K | 414K | 1.43M | 1.91M | 17K | 65K | 35K | 253K | 40K |
Income before tax | -6.91M | -17.86M | -32.46M | -28.77M | -20.46M | -9.78M | -12.29M | -16.84M | -10.62M | -9.10M |
Income tax expense | 0 | 705K | -519K | -1.16M | -1.92M | 75K | 12.36M | 106K | 21.24M | 1K |
Net income | -6.91M | -18.57M | -31.94M | -27.61M | -18.54M | -9.85M | -12.29M | -16.95M | -10.62M | -9.10M |
Earnings per share | ||||||||||
Basic EPS | -30.05 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 | -14.77 | -22.36 | -14.35 | -13.23 |
Diluted EPS | -29.95 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 | -14.77 | -22.36 | -14.35 | -13.23 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |